Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 4 | 2014 | 74 | 1.390 |
Why?
|
| Erythrocytes | 3 | 2018 | 146 | 1.170 |
Why?
|
| Diet | 5 | 2020 | 497 | 1.120 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2018 | 36 | 1.090 |
Why?
|
| Obesity | 13 | 2014 | 1166 | 0.970 |
Why?
|
| Dietary Sucrose | 2 | 2016 | 23 | 0.960 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2014 | 26 | 0.910 |
Why?
|
| Insulin | 4 | 2016 | 674 | 0.820 |
Why?
|
| Overweight | 3 | 2014 | 238 | 0.770 |
Why?
|
| Cognition | 4 | 2022 | 455 | 0.760 |
Why?
|
| Weight Loss | 4 | 2013 | 263 | 0.730 |
Why?
|
| Body Mass Index | 13 | 2016 | 831 | 0.670 |
Why?
|
| Brachial Artery | 6 | 2013 | 28 | 0.660 |
Why?
|
| Intra-Abdominal Fat | 4 | 2014 | 33 | 0.630 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2018 | 6 | 0.620 |
Why?
|
| Longitudinal Studies | 9 | 2022 | 1189 | 0.610 |
Why?
|
| Insulin Resistance | 4 | 2016 | 392 | 0.550 |
Why?
|
| Cognition Disorders | 1 | 2018 | 215 | 0.540 |
Why?
|
| Biomarkers | 5 | 2020 | 1305 | 0.520 |
Why?
|
| Puerto Rico | 6 | 2020 | 134 | 0.510 |
Why?
|
| Boston | 6 | 2020 | 246 | 0.500 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 788 | 0.490 |
Why?
|
| Lipogenesis | 1 | 2016 | 65 | 0.480 |
Why?
|
| Fatty Acids | 1 | 2016 | 190 | 0.470 |
Why?
|
| Endothelium, Vascular | 4 | 2011 | 169 | 0.460 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 9 | 0.460 |
Why?
|
| Dairy Products | 1 | 2014 | 15 | 0.450 |
Why?
|
| Oxidative Stress | 1 | 2016 | 279 | 0.450 |
Why?
|
| Beverages | 1 | 2014 | 66 | 0.440 |
Why?
|
| Vasodilation | 3 | 2010 | 35 | 0.420 |
Why?
|
| Child Development | 1 | 2014 | 79 | 0.420 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 96 | 0.410 |
Why?
|
| Diet, Mediterranean | 4 | 2020 | 16 | 0.380 |
Why?
|
| Prospective Studies | 6 | 2018 | 3065 | 0.380 |
Why?
|
| Male | 25 | 2022 | 27727 | 0.350 |
Why?
|
| Metabolic Syndrome | 3 | 2022 | 131 | 0.340 |
Why?
|
| Female | 26 | 2022 | 30696 | 0.340 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 74 | 0.330 |
Why?
|
| Middle Aged | 20 | 2020 | 16311 | 0.330 |
Why?
|
| Depression | 1 | 2016 | 828 | 0.320 |
Why?
|
| Blood Glucose | 5 | 2019 | 461 | 0.310 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 2373 | 0.300 |
Why?
|
| Risk Factors | 8 | 2022 | 4982 | 0.250 |
Why?
|
| Humans | 29 | 2022 | 59285 | 0.250 |
Why?
|
| Triglycerides | 3 | 2016 | 231 | 0.230 |
Why?
|
| England | 2 | 2014 | 24 | 0.230 |
Why?
|
| Waist Circumference | 2 | 2014 | 45 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 635 | 0.220 |
Why?
|
| Adipose Tissue | 3 | 2014 | 283 | 0.220 |
Why?
|
| Linear Models | 2 | 2016 | 402 | 0.220 |
Why?
|
| Subcutaneous Fat | 3 | 2014 | 46 | 0.220 |
Why?
|
| Cohort Studies | 5 | 2020 | 2372 | 0.210 |
Why?
|
| Cholesterol, LDL | 2 | 2016 | 102 | 0.210 |
Why?
|
| Phosphorus | 1 | 2022 | 16 | 0.200 |
Why?
|
| Kidney Diseases | 1 | 2022 | 169 | 0.180 |
Why?
|
| White Matter | 1 | 2022 | 114 | 0.180 |
Why?
|
| Ceramides | 1 | 2020 | 25 | 0.180 |
Why?
|
| Child | 3 | 2014 | 4173 | 0.170 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2020 | 48 | 0.170 |
Why?
|
| Cause of Death | 1 | 2020 | 210 | 0.160 |
Why?
|
| C-Reactive Protein | 4 | 2022 | 159 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2337 | 0.160 |
Why?
|
| Nutritional Status | 2 | 2019 | 93 | 0.160 |
Why?
|
| Adolescent | 3 | 2014 | 5822 | 0.160 |
Why?
|
| Food Supply | 1 | 2019 | 51 | 0.160 |
Why?
|
| Dietary Fats | 2 | 2019 | 173 | 0.160 |
Why?
|
| Protective Factors | 1 | 2018 | 33 | 0.150 |
Why?
|
| Eating | 1 | 2019 | 130 | 0.150 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2511 | 0.150 |
Why?
|
| Executive Function | 1 | 2018 | 61 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 741 | 0.140 |
Why?
|
| Self Report | 2 | 2022 | 359 | 0.140 |
Why?
|
| Hypertension | 1 | 2022 | 567 | 0.130 |
Why?
|
| Adult | 14 | 2019 | 15664 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 54 | 0.130 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 17 | 0.130 |
Why?
|
| Feeding Methods | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 71 | 0.130 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 68 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2013 | 495 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 309 | 0.130 |
Why?
|
| Cholesterol | 2 | 2013 | 252 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1236 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 515 | 0.120 |
Why?
|
| Ventricular Function, Left | 2 | 2014 | 257 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2016 | 365 | 0.120 |
Why?
|
| Diet Records | 1 | 2014 | 34 | 0.120 |
Why?
|
| Adolescent Development | 1 | 2014 | 15 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 33 | 0.110 |
Why?
|
| Pericardium | 1 | 2014 | 35 | 0.110 |
Why?
|
| DNA Damage | 1 | 2016 | 279 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 170 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2013 | 3 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 76 | 0.110 |
Why?
|
| Aged | 8 | 2022 | 13412 | 0.110 |
Why?
|
| Hyperemia | 1 | 2013 | 13 | 0.110 |
Why?
|
| Microcirculation | 1 | 2013 | 52 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 364 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 902 | 0.100 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 108 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 163 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 197 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 158 | 0.100 |
Why?
|
| Inflammation | 3 | 2022 | 1094 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1232 | 0.100 |
Why?
|
| Omentum | 1 | 2012 | 12 | 0.100 |
Why?
|
| Arterioles | 1 | 2011 | 7 | 0.100 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 12 | 0.090 |
Why?
|
| Homeostasis | 1 | 2013 | 346 | 0.090 |
Why?
|
| Prevalence | 1 | 2014 | 1252 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 68 | 0.090 |
Why?
|
| Phenotype | 2 | 2011 | 1136 | 0.080 |
Why?
|
| Choristoma | 1 | 2009 | 22 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2009 | 62 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 549 | 0.080 |
Why?
|
| Exercise | 1 | 2016 | 883 | 0.080 |
Why?
|
| Abdominal Fat | 1 | 2008 | 5 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 589 | 0.080 |
Why?
|
| Panniculitis | 1 | 2008 | 4 | 0.080 |
Why?
|
| Diet Surveys | 2 | 2019 | 41 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 1479 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2010 | 163 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 371 | 0.070 |
Why?
|
| Heart | 1 | 2009 | 274 | 0.070 |
Why?
|
| Energy Intake | 2 | 2019 | 167 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 2059 | 0.070 |
Why?
|
| Macrophages | 2 | 2011 | 1000 | 0.070 |
Why?
|
| Adipocytes | 1 | 2007 | 255 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 101 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 304 | 0.050 |
Why?
|
| Biological Availability | 1 | 2022 | 195 | 0.050 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2020 | 9 | 0.040 |
Why?
|
| Kidney | 1 | 2022 | 416 | 0.040 |
Why?
|
| Bone Density | 1 | 2020 | 129 | 0.040 |
Why?
|
| Food Analysis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Postmenopause | 1 | 2020 | 224 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 111 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 846 | 0.040 |
Why?
|
| Life Style | 1 | 2019 | 299 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2010 | 459 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2016 | 20 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 21 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 114 | 0.030 |
Why?
|
| Malnutrition | 1 | 2016 | 40 | 0.030 |
Why?
|
| Vietnam | 1 | 2016 | 165 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 679 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 88 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2017 | 254 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 28 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2014 | 26 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 192 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 107 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 168 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 230 | 0.030 |
Why?
|
| Biopsy | 1 | 2014 | 411 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 4266 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2012 | 19 | 0.020 |
Why?
|
| Papaverine | 1 | 2011 | 6 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2011 | 7 | 0.020 |
Why?
|
| Vasomotor System | 1 | 2011 | 21 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 63 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 52 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 10 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 110 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1025 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 19601 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 19 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1290 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 11 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 203 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 39 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 516 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 105 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 341 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 495 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1051 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 368 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 583 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 935 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 2888 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6071 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1464 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 10251 | 0.010 |
Why?
|